2024 Critical Care Congress Skip to main content
2024 Critical Care Congress Main banner
Back
ViewAttendees 441

Sepsis
One-Hour Concurrent Session

Rethinking Vasopressors: Evolving Evidence and Emerging Concepts in Vasopressor Administration

Sunday, January 21, 2024
10:30 AM – 11:30 AM MT
Location: North-120BCD
CE: 1.0

Vasopressors are among the most prescribed medications in the ICU. Particularly as fluid-restrictive approaches have become more common, vasopressors are becoming more prominent in the management of shock. However, the optimal approach to vasopressor administration remains unknown, so vasopressor administration practices vary widely and have broad implications for patient care, including safety and cost. This session will provide an in-depth overview of the latest evidence for vasopressor administration strategies in septic shock, including reviewing vasopressor choices, timing, and administration route, and will highlight important emerging concepts, including the role of vasopressor responsiveness, multimodal approaches, and opportunities for personalization.

Learning Objectives:

  • Evaluate the evidence behind common vasopressor administration practices
  • Identify vasopressor administration practices when high-quality evidence is lacking and ongoing research aimed at bringing data to inform practice in these areas
  • Examine existing practice variation in vasopressor administration and how this variation can inform vasopressor personalization, safety, and cost
  • Discuss emerging concepts in vasopressor administration, including multimodal approaches, vasopressor responsiveness, and their potential role in optimizing vasopressor practices

Presentations:

  • A Multimodal Approach: When Should We Reach Beyond Norepinephrine and Vasopressin?
  • Sooner or Later: When Should We Start to Add Vasopressors?
  • Ditching the Central Line: When Is a Peripheral IV Enough for Vasopressor Administration?